Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 16, 2025
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIV
Anne E M Kamphuis, Hylke Waalewijn, Roeland E Wasmann, et al.
The Lancet. Microbe
|
June 26, 2025
Centrifuge-free stool processing methods for Xpert MTB/RIF Ultra tuberculosis diagnosis in children in Uganda and Zambia: an observational, prospective, diagnostic accuracy study
Manon Lounnas, Eden Ngu Masama, Samuel Beneteau, et al.
AIDS (London, England)
|
August 29, 2025
Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children living with HIV in the CHAPAS-4 trial
Anne E M Kamphuis, Timo Kiezebrink, Hylke Waalewijn, et al.
Diagnostics (Basel, Switzerland)
|
July 2, 2021
Trial Design for a Diagnostic Accuracy Study of a Point-of-Care Test for the Detection of <i>Taenia solium</i> Taeniosis and (Neuro)Cysticercosis in Community Settings of Highly Endemic, Resource-Poor Areas in Zambia: Challenges and Rationale
Inge Van Damme, Chiara Trevisan, Kabemba E Mwape, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 22, 2021
Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization-Recommended Weight Band Doses and Formulations
Chishala Chabala, Anna Turkova, Anneke C Hesseling, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 1, 2023
Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change
Tom G Jacobs, Vivian Mumbiro, Moses Chitsamatanga, et al.
The Lancet. Child & Adolescent Health
|
March 24, 2024
Management of the infant born to a mother with tuberculosis: a systematic review and consensus practice guideline
Nadia Hasan, Clare Nourse, H Simon Schaaf, et al.
BMC Pediatrics
|
March 21, 2021
Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial
Aurélia Vessière, Hélène Font, Delphine Gabillard, et al.
The Journal of Antimicrobial Chemotherapy
|
September 20, 2024
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV
Lufina Tsirizani, Shaghayegh Mohsenian Naghani, Hylke Waalewijn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 14, 2023
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial
Hylke Waalewijn, Alexander J Szubert, Roeland E Wasmann, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 16, 2025
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIV
Anne E M Kamphuis, Hylke Waalewijn, Roeland E Wasmann, et al.
The Lancet. Microbe
|
June 26, 2025
Centrifuge-free stool processing methods for Xpert MTB/RIF Ultra tuberculosis diagnosis in children in Uganda and Zambia: an observational, prospective, diagnostic accuracy study
Manon Lounnas, Eden Ngu Masama, Samuel Beneteau, et al.
AIDS (London, England)
|
August 29, 2025
Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children living with HIV in the CHAPAS-4 trial
Anne E M Kamphuis, Timo Kiezebrink, Hylke Waalewijn, et al.
Diagnostics (Basel, Switzerland)
|
July 2, 2021
Trial Design for a Diagnostic Accuracy Study of a Point-of-Care Test for the Detection of <i>Taenia solium</i> Taeniosis and (Neuro)Cysticercosis in Community Settings of Highly Endemic, Resource-Poor Areas in Zambia: Challenges and Rationale
Inge Van Damme, Chiara Trevisan, Kabemba E Mwape, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 22, 2021
Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization-Recommended Weight Band Doses and Formulations
Chishala Chabala, Anna Turkova, Anneke C Hesseling, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 1, 2023
Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change
Tom G Jacobs, Vivian Mumbiro, Moses Chitsamatanga, et al.
The Lancet. Child & Adolescent Health
|
March 24, 2024
Management of the infant born to a mother with tuberculosis: a systematic review and consensus practice guideline
Nadia Hasan, Clare Nourse, H Simon Schaaf, et al.
BMC Pediatrics
|
March 21, 2021
Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial
Aurélia Vessière, Hélène Font, Delphine Gabillard, et al.
The Journal of Antimicrobial Chemotherapy
|
September 20, 2024
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV
Lufina Tsirizani, Shaghayegh Mohsenian Naghani, Hylke Waalewijn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 14, 2023
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial
Hylke Waalewijn, Alexander J Szubert, Roeland E Wasmann, et al.
Page
of 5